[Recommendations for secondary prevention of the clinical coronary cardiopathy].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control* / Q000628:therapy; D003920:Diabetes Mellitus / Q000628:therapy; D005951:Glucose Tolerance Test; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D006973:Hypertension / Q000628:therapy; D009765:Obesity / Q000628:therapy; D005082:Physical Exertion; D012008:Recurrence; D012907:Smoking; D013315:Stress, Psychological / Q000150:complications
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D003278:Contraceptives, Oral, Hormonal; D001241:Aspirin
Recomendaciones para la prevención secundaria de la cardiopatía coronaria clínica.